How much funding has Aillis raised?

Aillis has raised $35.0M in total funding, most recently a Series D round.

Who are Aillis's investors?

Aillis's investors include JSR Active Innovation Fund, Mirai Creation Fund.

Where is Aillis headquartered?

Aillis is headquartered in Tokyo, Japan.

What industry is Aillis in?

Aillis operates in Artificial Intelligence, Healthcare.

Aillis

Empowering all for co-creation in open healthcare

Tokyo, Japan · $35.0M raised

Artificial Intelligence

Healthcare

Headquarters: Tokyo
Employees: 51–200
Business Model: B2B
Website: aillis.jp

Total Funding: $35.0M
Last Round: $3.0M Series DNov 2024
Rounds: 2

About

Aillis, Inc. (アイリス株式会社) is a Japanese healthcare technology company on a mission to shape the future of healthcare by empowering all for co-creation. The company develops machine-learning-based AI diagnostics that use pharyngeal (throat) images instead of traditional swab specimens to enable easy, accurate, and early detection of influenza and other infectious diseases. Aillis builds medical AI technology to democratize access to diagnostic tools, working toward an open, collaborative healthcare ecosystem where medical knowledge and technology can be shared broadly across practitioners and patients.

Summary

Aillis is an Artificial Intelligence company based in Tokyo, Japan. It has raised $35.0M in total across 2 rounds, most recently a $3.0M Series D round in Nov 2024. Investors include JSR Active Innovation Fund and Mirai Creation Fund.